Guinness Asset Management’s Teva Pharmaceuticals TEVA Stock Holding History

Guinness Asset Management’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-383,806	Closed	-$12.8M	–	105
2017 Q2	$12.8M	Buy	383,806 +84,310	+28%	+$2.61M	2.7%	6
2017 Q1	$9.61M	Buy	299,496 +65,456	+28%	+$2.23M	2.14%	33
2016 Q4	$8.48M	Buy	234,040 +100,250	+75%	+$4M	2.04%	26
2016 Q3	$6.16M	Buy	133,790 +24,360	+22%	+$1.27M	1.55%	36
2016 Q2	$5.5M	Buy	109,430 +35,210	+47%	+$1.87M	1.51%	34
2016 Q1	$3.97M	Buy	74,220 +7,830	+12%	+$459K	1.21%	38
2015 Q4	$4.36M	Hold	66,390	–	–	1.78%	18
2015 Q3	$3.75M	Buy	+66,390	New	+$4.3M	1.75%	28

Other funds holding TEVA

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

HCM

Highfields Capital Management Boston, Massachusetts $68.3M AUM 21.64% 1-Year Est. Return

Northern Cross Boston, Massachusetts $279M AUM 1.98% 1-Year Est. Return

ACM

Abrams Capital Management Boston, Massachusetts $5.48B AUM 3.63% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Guinness Asset Management's TEVA Position: Q3 2017 in Review

Guinness Asset Management sold out of Teva Pharmaceuticals (TEVA) in Q3 2017, closing a stake of 383,806 shares — an estimated $12.8M sold.

Guinness Asset Management first reported a position in TEVA in Q3 2015 and held it in 8 quarters. The position peaked at $12.8M in Q2 2017. 537 funds tracked by Wall St. Rank hold TEVA as of Q3 2017.

Guinness Asset Management reported no remaining Teva Pharmaceuticals position as of Q3 2017 after selling out during the quarter.
Guinness Asset Management sold 383,806 Teva Pharmaceuticals shares in Q3 2017, an estimated $12.8M.
Guinness Asset Management first reported a position in Teva Pharmaceuticals in Q3 2015 and held it in 8 quarters.
Guinness Asset Management's Teva Pharmaceuticals position peaked at $12.8M in Q2 2017.
537 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q3 2017.

Based on Guinness Asset Management's 13F filing for Q3 2017, filed 13 Oct 2017.